By Dr Nicola Davies
Rare Disease Day is celebrated every year on February 28th. This year, the theme “share your colors” is a call to raise awareness for the over 7,000 rare diseases known to science, with focus on drug development, improved access to care, equity, and policy-making. In this article, we will dive into the latest research and drug development for a few select rare diseases (Duchenne muscular dystrophy and SCN8A), as well as examine the latest in policy-making by governments and non-governmental organizations across the world.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze